Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis

Therapy

Volumn 5, Issue 5, 2008, Pages 631-640

  Getts, Meghann Teague ^a   Getts, Daniel R ^a   Kohm, Adam P ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell survival; Demyelination; Endoplasmic reticulum stress response; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Myelin repair; Oligodendrocytes; OPC; Remyelination; Unfolded protein response

Indexed keywords

MYELIN;

CELL STRESS; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; DISEASE COURSE; DOWN REGULATION; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; REMYELINIZATION; REVIEW; TISSUE REPAIR;

EID: 64849083774     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.5.5.631     Document Type: Review

References (53)

1. Lucchinetti CF, Parisi J, Brunck W: The pathology of multiple sclerosis. Neurol. Clin. 23, 77-105 (2005).
2. Kantarci OH: Genetics and natural history of multiple sclerosis. Semin. Neurol. 28, 7-16 (2008).
3. Ebers GC: Environmental factors and multiple sclerosis. Lancet Neurol. 7. 268-277 (2008).
4. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (1998).
5. Ferguson B, Matyszak MK, Esiri MM, Perry VH: Axonal damage in acute multiple sclerosis lesions. Brain 120 (Pt 3), 393-399 (1997).
6. Trapp BD, Ransohoff R, Rudick R: Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12, 295-302 (1999).
7. Kohm AP, Turley DM, Miller SD: Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease. Int. Rev Immunol. 24, 361-392 (2005).
8. Rutkowski DT, Kaufman RJ: A trip to the ER: coping with stress. Trends Cell Biol. 14, 20-28 (2004).
9. Boyce M, Yuan J: Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 13, 363-373 (2006).
10. Malhotra JD, Kaufman RJ: The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 18, 716-731 (2007).
11. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D: Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2, 326-332 (2000).
12. Shen J, Chen X, Hendershot L, Prywes R: ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 3, 99-111 (2002).
13. Lee KP, Dey M, Neculai D, Cao C, Dever TE, Sicheri F: Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing. Cell 132, 89-100 (2008).
14. Ye J, Rawson RB, Komuro R et al.: ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 6, 1355-1364 (2000).
15. Chen X, Shen J, Prywes R: The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. J. Biol. Chem. 277, 13045-13052 (2002).
16. Harding HP, Zhang Y, Ron D: Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274 (1999).
17. de Haro C, Mendez R, Santoyo J: The eIF-2α kinases and the control of protein synthesis. FASEB J. 10, 1378-1387 (1996).
18. Zinszner H, Kuroda M, Wang X et al.: CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982-995 (1998).
19. Wang XZ, Lawson B, Brewer JW et al.: Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol. Cell Biol. 16, 4273-4280 (1996).
20. Lipson KL, Fonseca SG, Urano F: Endoplasmic reticulum stress-induced apoptosis and auto-immunity in diabetes. Curr. Mol. Med. 6, 71-77 (2006).
21. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R: An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902 (2001).
22. Wang HQ, Takahashi R: Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid. Redox Signal. 9, 553-561 (2007).
23. Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M: induction of neuronal death by ER stress in Alzheimer's disease. J. Chem. Neuroanat. 28, 67-78 (2004).
24. Katayama T, Imaizumi K, Sato N, et al.: Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat. Cell Biol. 1, 479-485 (1999).
25. Katayama T, Imaizumi K, Honda A et al.: Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations. J. Biol. Chem. 276, 43446-43454 (2001).
26. -/- mice reveals a role for translational control in secretory cell survival. Mol. Cell 7, 1153-1163 (2001).
27. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110 (2003).
28. 2+, leading induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54, 452-461 (2005).
29. Kawahara K, Oyadomari S, Gotoh T, Kohsaka S, Nakayama H, Mori M: Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett. 506, 135-139 (2001).
30. Oyadomari S, Takeda K, Takiguchi M et al.: Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl Acad. Sci. USA 98, 10845-10850 (2001).
31. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW: Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin. Neurol. Neurosurg. 106, 223-229 (2004).
32. Mhaille AN, McQuaid S, Windebank A et al.: Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 67, 200-211 (2008).
33. Patrikios P, Stadelmann C, Kutzelnigg A et al.: Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165-3172 (2006).
34. Chari DM: Remyelination in multiple sclerosis. Int. Rev. Neurobiol. 79, 589-620 (2007).
35. Keirstead HS, Blakemore WF: Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 56, 1191-1201 (1997).
36. Lucchinette C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122(Pt 12), 2279-2295 (1999).
37. Lin W, Bailey SL, Ho H et al.: The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117, 448-456 (2007).
38. Lin W, Kemper A, Dupree JL, Harding HP, Ron D, Popko B: Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129, 1306-1318 (2006).
39. Lees JR, Cross AH: A little stress is good: IFN-γ, demyelination, and multiple sclerosis. J. Clin. Invest. 117, 297-299 (2007).
40. Hung CC, Ichimura T, Stevens JL, Bonventre JV: Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J. Biol. Chem. 278, 29317-29326 (2003).
41. Williams BL, Lipkin WI: Endoplasmic reticulum stress and neurodegeneration in rats neonatally infected with borna disease virus. J. Virol. 80, 8613-8626 (2006).
42. Saito A, Hino S, Murakami T, Kondo S, Imaizumi K: A novel ER Stress transducer, OASIS, expressed in astrocytes. Antioxid. Redox Signal. 9, 563-571 (2007).
43. Kondo S, Saito A, Hino S et al.: BBF2H7, a novel transmembrane bZIP transcription factor, is a new type of endoplasmic reticulum stress transducer. Mol. Cell Biol. 27, 1716-1729 (2007).
44. Isler JA, Skalet AH, Alwine JC: Human cytomegalovirus infection activates and regulates the unfolded protein response. J. Virol. 79, 6890-6899 (2005).
45. Correale J, Fiol M, Gilmore W: The risk of relapses in multiple sclerosis during systemic infections. Neurology 652-659 (2006).
46. Willenbord DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA: IFN-γ plays a critical dowm-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-3227 (1996).
47. Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, Cowden WB: IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163, 5278-5286 (1999).
48. Gao X, Gilling TA, Ye P, D'Ercole AJ, Matsushima GK, Popko B: Interferon-γ protects against cuprizone-induced demyelination. Mol. Cell. Neurosci. 16, 338-349 (2000).
49. Balabanov R, Strand K, Goswami R et al.: Interferon-γ-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J. Neurosci. 27, 2013-2024 (2007).
50. Panitch HS, Hirsh RL, Schindler J, Johnson KP: Treatment of multiple sclerosis with γ-interferon: exacerbations associated with activation of the immune system, Neurology 37, 1097-1102 (1987).
51. Frederick TL, Miller SD: The future of MS therapy - combining antigen-specific immunotherapy with myelin repair strategies. Future Neurol. 1, 489-503 (2006).
52. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP: TNFα promotes proliferation of oligodendrocyte prognitors and remyelination. Nat. Neurosci. 4, 1116-1122 (2001).
53. Mason JL, Suzuki K, Chaplin DD, Matsushima GK: Interleukin-1β promotes repair of the CNS. J. Neurosci. 21, 7046-7052 (2001).